0000899243-19-024656.txt : 20191002
0000899243-19-024656.hdr.sgml : 20191002
20191002160728
ACCESSION NUMBER: 0000899243-19-024656
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191001
FILED AS OF DATE: 20191002
DATE AS OF CHANGE: 20191002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seymour Albert
CENTRAL INDEX KEY: 0001735324
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38433
FILM NUMBER: 191132293
MAIL ADDRESS:
STREET 1: C/O HOMOLOGY MEDICINES, INC.
STREET 2: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Homology Medicines, Inc.
CENTRAL INDEX KEY: 0001661998
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473468154
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 781-301-7277
MAIL ADDRESS:
STREET 1: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-01
0
0001661998
Homology Medicines, Inc.
FIXX
0001735324
Seymour Albert
C/O HOMOLOGY MEDICINES, INC.
ONE PATRIOTS PARK
BEDFORD
MA
01730
0
1
0
0
Chief Scientific Officer
Common Stock
2019-10-01
4
S
0
9200
17.3844
D
181850
D
Common Stock
2019-10-01
4
S
0
100
18.23
D
181750
D
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018.
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $17.09 to $17.85. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Bradford Smith, Attorney-in-Fact for Albert Seymour
2019-10-02